The diagnostic delay in migraine disease
In a 2017 global study evaluating disease burden, headache disorders—most commonly identified as migraine—were the 2nd most disabling disease.1 Assuming a 7.4 billion population in 2016, the global prevalence of migraine is estimated to be approximately 14%2, however, up to 45% of headache patients still seek care at headache centers around the
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now